Why High-Dose NMN May Be Backfiring — What the Research Actually Shows
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →About this video
Creator description · original textText language: English
David Sinclair takes one gram of NMN daily. The human trials with the
best functional outcomes used 250 milligrams. Most people are somewhere
in between — based on what they read, not what the research shows.
This video breaks down:
• What dose the major human NMN trials actually used (and what they found)
• The CD38 "ceiling effect" that limits returns at high doses
• The 2023 Nature Metabolism paper on NAD+ and cancer cells (and what it actually means)
• Why Sinclair's one-gram dose is self-selected, not clinically derived
• Peter Attia's position on NMN — and why it's also reasonable
• Age-based dosing breakdown: under 45, 45–65, 65+
---
TIMESTAMPS
0:00 — The NMN dose question: is 1 gram actually better?
0:35 — Why “more NMN = more benefit” is not always true
1:28 — What this video is — and is not — saying about NMN safety
2:06 — Major human NMN trials and the doses they actually tested
3:14 — 2024 meta-analysis: where functional benefits appear strongest
3:55 — The cancer-metabolism concern around high NAD+ levels
5:21 — CD38: the “NAD+ vampire” and the ceiling effect
6:50 — Why David Sinclair takes 1 gram — and what that really means
7:37 — Peter Attia’s more cautious position on NMN
8:05 — Why age changes the ideal NMN dose
9:17 — Practical NMN dose guide by age group
9:55 — Cancer history: talk to your oncologist before NAD+ precursors
10:07 — Timing and absorption still matter regardless of dose
10:20 — Next topic: why NMN brand quality matters
---
STUDIES REFERENCED
• NMN 250mg RCT in older men — Keio University, 2021 (Cell Metabolism)
• NMN 1,000mg trial in postmenopausal women — Washington University, 2022
• MIB-626 (NMN) high-dose trial — 2023
• NAD+ and cancer metastasis — Nature Metabolism, 2023
• NMN human trial meta-analysis — npj Aging, 2024
---
DISCLAIMER — AI CONTENT & HEALTH
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
AI CONTENT: This video features an AI-generated presenter
(Dr. James Chen), AI voiceover, and AI-assisted visuals.
Dr. James Chen is a synthetic AI wellness educator —
not a real person or licensed physician.
HEALTH: All content is for educational purposes only and
does not constitute medical advice, diagnosis, or treatment.
Consult a qualified healthcare provider before starting any
supplement protocol or making significant lifestyle changes —
especially if you are pregnant, nursing, on medication,
or managing a chronic condition.
Individual results vary. Studies referenced are linked above.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
---
Longevity Lab covers the science of aging without supplement
industry spin. New video every week.
```
Longevity Lab · 11 min · Source published: 2026-05-18
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.